IRM India’s What’s The Risk? ® Interview With Viraj Kapur, Co-Founder And Director At Salt Oral Care
In this interview, Hersh Shah, CEO, IRM India Affiliate and India’s Youngest Enterprise Risk Expert interacts with Viraj ...
KJCT81h
Family searching for missing heirloom drawing
For as long as the Ortiz family can remember, a charcoal drawing their great-great-grandmother drew has been hanging on a ...
The American Spectator4h
In Praise of G-d and of His Agent for Change — Kamala Harris
I was among the first — maybe the first — to publish in a serious journal (this one) exactly who and what Kamala Harris is.
federalnewsnetwork.com5h
Trump’s picks for key positions in his second administration
President-elect Donald Trump has filled key posts for his second term in office, prioritizing loyalty to him after he felt bruised and hampered by internal squabbles during his first term. Among his ...
Observer8h
Framing Art History’s Most Famous Friendships—and Fallouts
When Vincent van Gogh painted his glorious sunflowers in Arles, every single one of them was for Paul Gauguin, whom he’d ...
Daily Maverick on MSN10h
Saru vote for equity sale faces major barriers from dissident unions still unhappy with structure
After a delay and weeks of lobbying and negotiations, a vote by the South African Rugby Union’s (Saru) general council to accept or reject an equity sale for a minority stake in the organisation will ...
The Sports Report: Lakers just can’t score in loss to Minnesota
The 80 points is the Lakers’ worst offensive game in LeBron James’ time with the team and the worst overall since 2017.
Quad-City Times20h
'Everybody’s battening down the hatches;' Farmers worry about length of downturn
Through 2024, Corn has dropped from an average of $4.74 per bushel in January to $3.98 in September, according to NASS ...
carolinapublicpress.org1d
Did homes along lake have to flood? Residents and Duke Energy disagree.
Federal agency hasn't yet weighed in on whether Duke's timing of water releases from dams near Mountain Island Lake was ...
FierceBiotech1d
FDA rejects Applied filing for rare disease approval on clinical grounds, sinking stock
The FDA has rejected Applied Therapeutics’ attempt to win approval on the strength of a failed phase 3 trial, triggering a 75 ...
48 hills2d
In the Trump era, what’s next for DSA?
The curious also came, eager to learn more of what the whole thing was all about, maybe suffering from imposter syndrome: “Do ...